Diabetes Digital Health. This item is unavailable.Diabetes Digital Health

Diabetes Digital Health brings together the multifaceted information surrounding the science of digital health from an academic, regulatory, industrial, investment and cybersecurity perspective. Clinicians and researchers who are developing and evaluating mobile apps for diabetes patients will find this essential reading, as will industry people whose companies are developing mobile apps and sensors.

• Provides valuable information for clinicians, researchers and industry about the design and evaluation of patient-facing diabetes adherence technologies
• Highlights cutting-edge topics that are presented and discussed at the Digital Diabetes Congress

Dr. David C. Klonoff, MD, FACP, FRCP (Edin), is an endocrinologist specializing in the development of diabetes technology. He is Medical Director of the Dorothy L. and James E. Frank Diabetes Research Institute of Mills-Peninsula Medical Center in San Mateo, California and a Clinical Professor of Medicine at UCSF, USA. Dr. Klonoff received the American Diabetes Association’s 2019 Outstanding Physician Clinician Award. He has received an FDA Director’s Special Citation Award for outstanding contributions related to diabetes technology. He is the Founding Editor-in-Chief of Journal of Diabetes Science and Technology and co-founded the Digital Diabetes Congress. He chairs the Scientific Advisory Board for the Texas A&M University Precise Advanced Technologies and Health Systems for Underserved Populations (PATHS-UP) Engineering Research Center. He is currently researching new devices and drugs for diabetes. Dr. Klonoff graduated from UC Berkeley and UCSF Medical School and did five years of internal medicine and endocrinology training at UCLA and UCSF.

David Kerr MBChB, DM, FRCP, FRCPE, is a UK trained endocrinologist and has recently joined Sutter Health after spending almost a decade as a researcher/innovator in Santa Barbara, CA (https://www.davidkerrmd.com/). This began in 2014, with David’s appointment as Director of Research and Innovation at Sansum Diabetes Research Institute before moving to the Diabetes Technology Society as their lead for Digital Health last year. David has now joined Sutter Health as Senior Investigator, Diabetes Research and Digital Health Equity.

David’s recent research has focused on offering wearable digital health technologies such as continuous glucose monitors to marginalized and historically excluded communities to help understand the potential value of real time physiological data. He has published more than 400 articles, commentaries and opinion pieces as well as co-authoring the first two books focusing on diabetes and digital health.

David’s research has also included the use of “food-as-medicine” for adults with or at-risk of diabetes. As part of this research, increasing participation in clinical research by traditionally hard to reach communities has been achieved through the creation of specially trained “Community Scientists” from the same communities. David also has an adjunct position in the Dept of Computer Science and Electrical Engineering at Rice University in Houston Texas, and recently co-Chair of an NIDDK working group looking at the impact of innovation on furthering research into the heterogeneity of diabetes.

You can follow David on ‘X’ at @godiabetesmd.

Shelagh Mulvaney, PhD, is an Associate Professor and pediatric psychologist at Vanderbilt University. Her research focuses on integrating behavioral science into the design and evaluation of technology-mediated self-management support systems for adolescents and young adults with diabetes. Central to her research are technologies and processes that engage patients in their daily health behaviors including mobile technologies, social learning mechanisms, and self-care problem solving. A primary focus of her work is on momentary assessment of affect, cognition, and behavior for personalized feedback and health communications.